Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 292.50
-32.00 (-9.86%)
At close: Feb 11, 2026
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 76.92 billion as of February 20, 2026. Its market cap has increased by 10.41% in one year.
Market Cap
76.92B
Enterprise Value
83.67B
Revenue
18.66B
Ranking
n/a
PE Ratio
16.21
Stock Price
292.50
Market Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 76.92B, an increase of 737.25%. That is a compound annual growth rate of 20.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 76.92B | 3.36% |
| Dec 31, 2025 | 74.42B | 4.05% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 268.14B |
| Bora Pharmaceuticals | 60.77B |
| Center Laboratories | 29.86B |
| TTY Biopharm Company | 20.81B |
| Grape King Bio | 18.07B |
| Alar Pharmaceuticals | 17.87B |
| ScinoPharm Taiwan | 17.12B |
| Synmosa Biopharma | 16.25B |